Altre lingue Sanofi

Azioni

SAN

FR0000120578

Tempo reale Euronext Paris Altri mercati azionari 17:36:34 12/09/2024			Variaz. 5gg	Var. 1 gen.
102,80 ^EUR	-1,68%		-2,02%	+14,53%

17:10	Sanofi firma un accordo di licenza con RadioMedix e Orano Med per AlphaMedix	MT
14:36	SANOFI : CIC Market Solutions rivaluta il giudizio Buy e il rating passa a Neutral	ZM

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Sanofi : nouvelle approbation pour Dupixent au Canada	17:16
Sanofi Signs Licensing Deal With RadioMedix, Orano Med for AlphaMedix	17:10
Regeneron Pharmaceuticals - Dupixent Phase 3 Trial Confirms Significant Improvements in Itch and Hives for Patients with Chronic Spontaneous Urticaria	16:45
Sanofi - Dupixent phase 3 study confirms significant improvements in itch and hives for patients with CSU	16:45
Sanofi - Dupixent is the first and only biologic to achieve significant improvements in disease remission and symptoms in bullous pemphigoid positive pivotal study	16:42
Enzyme replacement therapy: improving outcomes in rare disease	16:31
MIDDAY BRIEFING - Unternehmen und Märkte -2-	13:20
ECB to cut rates without lowering its guard	13:19
Moderna expects up to $3.5 billion in 2025 sales	12:14
Dumme Frage: Warum ändern börsennotierte Unternehmen ihre Namen?	11:20
Sanofi acquiert une licence pour une radiothérapie innovante contre des cancers	10:47
Sanofi Teams Up With RadioMedix, Orano in $352 Million Deal for Cancer Therapy -- Update	09:18
Sanofi Teams Up With RadioMedix, Orano in $352 Million Deal for Cancer Therapy -- Update	09:18
En Direct des Marchés : Stellantis, Airbus, Alstom, DSV, Fevertree, Nvidia, ABN Amro...	08:51
Linedata Services : Alstom, Linedata, Sanofi... les valeurs à suivre aujourd'hui à Paris	08:50
Avis d'analystes du jour : TotalEnergies, Alten, Legrand, Veolia, Unibail, Pluxee, Safran, BMW...	08:44
Accord de licence entre Sanofi, RadioMedix et Orano Med pour le développement d’une nouvelle génération de radiothérapies internes vectorisées contre les cancers rares	08:38
Sanofi, RadioMedix, and Orano Med Announce Licensing Agreement on Next-Generation Radioligand Medicine for Rare Cancers	08:38
Le CAC 40 devrait ouvrir en nette hausse avant son rendez-vous avec la BCE	08:34
Sanofi : A suivre aujourd'hui	08:12